mailed
on 17 Oct 2024
Last Applicant/ Owned by
1792 Bell Tower Lane
Weston
FL
33326
Serial Number
98043024 filed on 14th Jun 2023
Registration Number
N/A
Correspondent Address
Michael J. Belliveau
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Development of new drugs for the prevention and treatment of cancer and other serious illnesses; Design and testing of new drugs and therapies; Medical and scientific research in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, Read More
Licensing of pharmaceuticals and drug discovery technologies
N/A
N/A
Providing medical and scientific research information about the diagnosis and treatment of diseases, namely, infectious diseases, viral diseases, and autoimmune diseases; Providing information in the fields of health, wellness, and pharmaceuticals via a website; all of the foregoing related to Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses
N/A
N/A
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Development of new drugs for the prevention and treatment of cancer and other serious illnesses; Design and testing of new drugs and therapies; Medical and scientific research in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Medical and scientific research consulting in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Biological testing and research in the field of pharmaceuticals; all of the foregoing related to Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases
N/A
N/A
Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for inhibiting Receptor for Advanced Glycation End products (RAGE) interactions, for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Pharmaceutical preparations for use in personalized medicine and targeted therapy in the field of Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases
N/A
N/A
No 98043024
No Service Mark
No 51849-T02001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Oct 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
28th Oct 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
28th Oct 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
28th Oct 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
28th Oct 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
23rd Oct 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
23rd Oct 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
17th Oct 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
17th Oct 2024 | SUSPENSION LETTER WRITTEN |
17th Oct 2024 | LETTER OF SUSPENSION E-MAILED |